The clear message from the XVI International AIDS Conferencein Toronto in August was that the growth of the pandemic continuesto outpace the broad and expanding efforts to control it. Theconference had 26,057 participants, a record number. The meeting'stheme — "time to deliver" — suggested both ongoingurgency and frustration at the pace of the response. The WorldHealth Organization (WHO) never came close to its goal of providingantiretroviral medications to 3 million people by the end of2005. In June 2006, an estimated 1.65 million people in low-and middle-income countries were receiving antiretroviral therapy,. . . [Full Text of this Article]
Source Information
Dr. Steinbrook (rsteinbrook@attglobal.net) is a national correspondent for the Journal.
An interview with Mark Wainberg, cochair of the XVI International AIDS Conference, can be heard at www.nejm.org.
This article has been cited by other articles:
Garrido, C., Zahonero, N., Fernandes, D., Serrano, D., Silva, A. R., Ferraria, N., Antunes, F., Gonzalez-Lahoz, J., Soriano, V., de Mendoza, C.
(2008). Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J Antimicrob Chemother
61: 694-698
[Abstract][Full Text]
Interview
